Press Release

Jul 25, 2018
Cytox presentation at AAIC 2018 now available

See Cytox’s presentation at AAIC 2018, ‘Stratification of Individuals for PET Amyloid Positivity and Alzheimer’s Disease Risk Using Polygenic Risk Score Analysis – new opportunities for clinical trial design’ for our latest results on identifying Alzheimer’s disease risk in ApoE3 homozygote individuals, and also identifying those individuals most likely to progress from MCI to AD.